Ignite Creation Date:
2025-12-25 @ 4:02 AM
Ignite Modification Date:
2026-01-29 @ 1:17 AM
Study NCT ID:
NCT00895102
Status:
COMPLETED
Last Update Posted:
2010-10-13
First Post:
2009-05-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioavailability of ABT-333 Tablet Versus First in Human (FIH) Capsule Formulation and Safety, Tolerability and PK Study of Single Doses of ABT-333 in Healthy Volunteers
Sponsor:
Abbott
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
M11-032
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Daniel Cohen, MD/Study Medical Director
Old Organization:
Abbott